...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >An early-stage, non-hypervascular HCC successfully treated by superselective, bland transarterial embolization using 40-μm microspheres.
【24h】

An early-stage, non-hypervascular HCC successfully treated by superselective, bland transarterial embolization using 40-μm microspheres.

机译:早期非血管性肝癌通过使用40μm微球的超选择性,温和的经皮动脉栓塞术成功治疗。

获取原文
获取原文并翻译 | 示例

摘要

Transcatheter embolization is considered to be less effective for early-stage hepatocellular carcinomas (HCCs) without a hypervascular arterial supply. In the present case report, a 65-year-old male with hepatitis type C and non-hypervascular HCC located in the hepatic hilum was successfully treated by bland transarterial embolization (TAE). After the temporary protective embolization of normal liver tissue using large gelatin particles, diluted 40-μm microspheres were injected via the tumor-feeding artery. The tumor shrank, and the patient has survived for 25 months without recurrence.
机译:经导管栓塞术被认为对没有肝动脉供血过多的早期肝细胞癌(HCC)无效。在本病例报告中,一名65岁的丙型肝炎和位于肝门的非超血管HCC的男性已通过平直的动脉栓塞术(TAE)成功治疗。在使用大明胶对正常肝组织进行临时性保护栓塞后,通过肿瘤喂养动脉注射稀释的40μm微球。肿瘤缩小,患者存活了25个月而未复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号